Free Trial

Indaptus Therapeutics (INDP) SEC Filings & 10K Form

Indaptus Therapeutics logo
$0.46 -0.01 (-2.13%)
As of 04/30/2025 04:00 PM Eastern

Recent Indaptus Therapeutics SEC Filings

DateFilerForm TypeView
04/28/2025
3:25 PM
Indaptus Therapeutics (Filer)
Form ARS
04/28/2025
3:15 PM
Indaptus Therapeutics (Filer)
Form DEF 14A
03/13/2025
11:15 PM
Indaptus Therapeutics (Filer)
Form EFFECT
03/13/2025
6:35 AM
Indaptus Therapeutics (Filer)
Form POS AM
03/13/2025
6:40 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:30 AM
Indaptus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
11:15 PM
Indaptus Therapeutics (Filer)
Form EFFECT
02/12/2025
10:38 AM
Indaptus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/11/2025
11:15 PM
Indaptus Therapeutics (Filer)
Form EFFECT
02/05/2025
3:17 PM
Indaptus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/31/2025
3:15 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
4:01 PM
Indaptus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/14/2025
3:15 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/01/2025
11:15 PM
Indaptus Therapeutics (Filer)
Form EFFECT
12/23/2024
3:52 PM
Indaptus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/06/2024
3:36 PM
Indaptus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/22/2024
3:48 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
7:05 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:21 PM
Indaptus Therapeutics (Filer)
Form D/A
09/22/2024
11:15 PM
Indaptus Therapeutics (Filer)
Form EFFECT
09/12/2024
3:45 PM
Indaptus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/22/2024
9:06 AM
Indaptus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/12/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:01 AM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:16 AM
Indaptus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
4:30 PM
Indaptus Therapeutics (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:28 PM
Indaptus Therapeutics (Filer)
Form 424B5
08/06/2024
4:23 PM
Indaptus Therapeutics (Filer)
Form 424B5
06/07/2024
3:30 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:05 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:06 AM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INDP) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners